Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer. - Wikidata - awgldk - TriplyDB

Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer.

Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer.

http://www.wikidata.org/entity/Q36613812

about

Functional and Biological Role of Endothelial Precursor Cells in Tumour Progression: A New Potential Therapeutic Target in Haematological Malignancies Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies The synergistic effect of everolimus and chloroquine on endothelial cell number reduction is paralleled by increased apoptosis and reduced autophagy occurrence Tumor angiogenesis Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents.Effects of recombinant human endostatin and its synergy with cisplatin on circulating endothelial cells and tumor vascular normalization in A549 xenograft murine model.Late release of circulating endothelial cells and endothelial progenitor cells after chemotherapy predicts response and survival in cancer patients.Efficient in vivo selection of a novel tumor-associated peptide from a phage display library.Role of endothelial progenitors and other bone marrow-derived cells in the development of the tumor vasculature A prospective pilot study of circulating endothelial cells as a potential new biomarker in portal hypertension.Targeting of the breast cancer microenvironment with a potent and linkable oxindole based antiangiogenic small molecule.Circulating mouse Flk1+/c-Kit+/CD45- cells function as endothelial progenitors cells (EPCs) and stimulate the growth of human tumor xenografts.Nerve growth factor promotes breast cancer angiogenesis by activating multiple pathways.A new approach for rapid and reliable enumeration of circulating endothelial cells in patients.Anthracycline cardiotoxicity: from bench to bedside.Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy.A subpopulation of circulating endothelial cells express CD109 and is enriched in the blood of cancer patients.Development of a new positron emission tomography tracer for targeting tumor angiogenesis: synthesis, small animal imaging, and radiation dosimetry.Mechanisms of resistance to anti-angiogenic therapy and development of third-generation anti-angiogenic drug candidates.Expression of Hypoxia-inducible factor 1-α and vascular endothelial growth factor-C in locally advanced breast cancer patients.Isolation and characterization of endothelial progenitor cells from Rhesus monkeys.Targeting angiogenesis in esophagogastric adenocarcinoma.Effect of standard chemotherapy and antiangiogenic therapy on plasma markers and endothelial cells in colorectal cancer.A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).Issues regarding improving the impact of antiangiogenic drugs for the treatment of breast cancer Endothelial precursor cells promote angiogenesis in hepatocellular carcinoma.Microvascular Function and Endothelial Progenitor Cells in Patients with Severe Hypercholesterolemia and the Familial Hypercholesterolemia Phenotype.Dopamine regulates endothelial progenitor cell mobilization from mouse bone marrow in tumor vascularization The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer.The multifaceted circulating endothelial cell in cancer: towards marker and target identification.Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression.Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activity.Bevacizumab specifically decreases elevated levels of circulating KIT+CD11b+ cells and IL-10 in metastatic breast cancer patients.Clinical biomarkers of angiogenesis inhibition.Alterations of circulating bone marrow-derived VEGFR-2+ progenitor cells in isolated limb perfusion with or without rhTNF-α.Circulating endothelial cells in oncology: pitfalls and promises Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index.HIF2alpha cooperates with RAS to promote lung tumorigenesis in mice ENDOGLIN/CD105 is expressed in KIT positive cells in the gut and in gastrointestinal stromal tumours Blood-based biomarkers for the optimization of anti-angiogenic therapies

P2860

Q26770838-BEA3D795-C30E-43B6-A608-597854282E63 Q26783705-1C5F911F-4B92-4897-81DA-FA62F76F749E Q28534969-1EC79170-63D3-4AC6-8AC7-DC0A20821D3C Q29614938-BF14D0CD-61C1-4435-8E3D-04731E18D8B8 Q30438696-B25728FE-BBB8-43A5-BCC4-88B82168BFE9 Q31050181-BA774EA4-983B-4AFD-8369-57095575BE21 Q33588306-8DC0F0B2-5A23-4608-BF9E-501DDD5E62C6 Q33800886-1C941240-9704-454B-B170-1769D0E5C162 Q33824295-1D9ECF74-EF38-4852-A8C7-A430A7618763 Q33843701-35001662-4522-4989-8441-944964CE4910 Q33913901-7B2CD598-8308-4A80-BAB1-6DA1A868A676 Q33958649-8DFAD50A-5BCF-459F-8312-E084BC968FC5 Q33981022-02836CAB-127C-4795-854D-CE40BB0B93F3 Q34183354-569041D3-744F-4C4A-A6B1-C62F53D5A47B Q34477415-7DA65692-9F08-42BD-9FA1-A9BB56940A7F Q34523039-C616D275-00AC-4205-B55D-85280FEE44E1 Q34703792-C5A7D116-FD83-428C-8348-8D8334838577 Q34724473-5BD729F0-28FC-43E0-A960-067FA18D703E Q34972161-F42B876C-A82F-4A98-B425-85FC5A6CFF8E Q35179664-F58C1448-1E58-43D6-A897-A50C17EED31D Q35321370-09318311-8752-417D-9CFA-5A4375BEC19C Q35584958-8A5DFE5A-4D95-478C-834C-4A1D80793547 Q35678109-CB9A99DA-9C34-4ADB-B344-51B2C0C7CC2B Q35917810-40688801-73B6-46AB-BFCF-6AAE3D4C6C09 Q35966791-0C5B6976-911F-4C52-B04B-47AD39333D45 Q36248210-EF9598A7-641C-44A8-A2AB-56094C78F127 Q36362162-C39406D4-1D47-433C-BF4B-0957C846582D Q36494552-4FE970BD-5ECA-4545-A71F-464995CCBE7A Q36612601-A690542D-5494-43EB-BA93-EAB7098D70E9 Q36621435-B07DB165-B38A-44CB-BD8B-E9DF47192B75 Q36831312-BA35C53D-04D0-488E-9CD1-9493376261AA Q36977587-AA222200-0B68-45DB-A814-A85F144BD5F3 Q36998185-D16905AA-5110-4D5B-834A-F94004749D42 Q37139413-7D46DD69-299E-4364-8DAA-81DA788C02B0 Q37150166-E9772FC2-AA11-426D-9422-9514FE85840D Q37174401-CC361B4C-82A5-4ADB-87EF-B342721BCCDA Q37269351-E87E1A91-771D-439F-B4EC-69D5A702CF14 Q37286696-248C2B6A-C40D-4BD8-8AA6-1FFCC9096346 Q37295765-BA4B0DA8-D4CD-4001-9916-19276BBB615D Q37328390-D19E6428-8701-45E6-8B7D-4E339D9BD692

P2860

Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer.

http://www.wikidata.org/entity/Q36613812

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Circulating endothelial cells ...... rapy of primary breast cancer.

@ast

Circulating endothelial cells ...... rapy of primary breast cancer.

@en

type

label

Circulating endothelial cells ...... rapy of primary breast cancer.

@ast

Circulating endothelial cells ...... rapy of primary breast cancer.

@en

prefLabel

Circulating endothelial cells ...... rapy of primary breast cancer.

@ast

Circulating endothelial cells ...... rapy of primary breast cancer.

@en

P1433

Q36613812-86F377F0-3B2F-4E16-BA21-1A12889EC230

P1476

Q36613812-5C46C225-2B3E-433D-9554-A2AF9E303E75

P2093

Q36613812-393E2BA2-33B9-4ED8-855E-D5E5887A69C4

Q36613812-5F5125E6-C7C3-4EF3-9E81-EB6035D5BBF2

Q36613812-5FB676DF-5B99-4F02-B575-E06174D1A2E8

Q36613812-64B10EC3-F614-43F8-8C39-31A8D26CFF7E

Q36613812-B0C2BB9A-D17B-4D11-A690-AE9CEA1DC5F1

Q36613812-D63786C7-0A8E-4050-AAC9-93F68B0C33E2

P2860

Q36613812-03C025AC-4FB0-4728-96C0-E8DB678D441A

Q36613812-18675D5C-F76F-43F0-AF02-10B78D1338D8

Q36613812-1BF8CA38-E65A-41EC-B703-BA90802854F8

Q36613812-259B694E-39BA-4F6D-A123-C283A721C12E

Q36613812-348B7E59-3A28-4D46-BD9A-A04F6F26C172

Q36613812-34E3E5BF-A982-4D7F-9F22-56C42FEB4E53

Q36613812-46F174F8-2F51-4A78-ABFE-9D8D50D87F7E

Q36613812-597E343B-B4F7-4898-B6AE-90ED7CDDC209

Q36613812-8396EE53-E820-4E68-A2B8-57AE42ECEC8B

Q36613812-8C52723A-060E-4238-B8E3-4225F97ADDD8

P2888

Q36613812-C381D7A6-0B13-4A0B-951E-4B14484B8532

P304

Q36613812-C91AE571-CD22-477B-BA8C-296C1556EC37

P31

Q36613812-99EF8C05-BA14-4896-8B77-C0570EEDB5A6

P356

Q36613812-F3ED776D-8DE1-45E6-AFDF-20851BF65D0A

P407

Q36613812-F47D5CBC-F40B-4ABF-948F-B6386BCBB16C

P433

Q36613812-CBE119E1-BF08-416D-BD62-BD2331C46944

P478

Q36613812-CA10D444-2A57-44AC-8286-FC167F65C4D2

P50

Q36613812-2076EE7A-D527-4536-9796-A4E0935CC506

P577

Q36613812-DE39CB7D-99CF-42DB-89E3-0CAEF4328740

P5875

Q36613812-3476AD15-F6C4-44A0-B884-0DB0196DB12C

P6179

Q36613812-E4AFDD9E-B152-4DCC-8DC1-D7A0868579A4

P698

Q36613812-DE956DCE-1083-4E44-AAFE-5450C197C49D

P921

Q36613812-1919E8BE-7A0C-4AFA-A73D-6FCF36E1D2D9

Q36613812-F0924471-2582-484B-96E7-9CEBA2FB918A

P932

Q36613812-DC82D87E-40B7-430F-81C1-3061F6E84794

P356

P1433

British Journal of Cancer

P1476

Circulating endothelial cells ...... rapy of primary breast cancer.

@en

P2093

B Thürlimann

http://www.w3.org/2001/XMLSchema#string

E-M Boneberg

http://www.w3.org/2001/XMLSchema#string

G Fürstenberger

http://www.w3.org/2001/XMLSchema#string

H-J Senn

http://www.w3.org/2001/XMLSchema#string

J Hamacher

http://www.w3.org/2001/XMLSchema#string

R von Moos

http://www.w3.org/2001/XMLSchema#string

P2860

Origins of circulating endothelial cells and endothelial outgrowth from blood

Secreted cathepsin L generates endostatin from collagen XVIII

Isolation of putative progenitor endothelial cells for angiogenesis

Generation and degradation of human endostatin proteins by various proteinases

Tumorigenesis and the angiogenic switch

Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization.

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization.

Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors.

Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors.

Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?

P2888

P304

524-531

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6602952

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7324017

http://www.w3.org/2001/XMLSchema#string

P6179

1051787522

http://www.w3.org/2001/XMLSchema#string

P698

16450002

http://www.w3.org/2001/XMLSchema#string

P921

P932

2361171

http://www.w3.org/2001/XMLSchema#string